|

BRAF inhibitor dabrafenib and MEK inhibitor trametinib Clinical Trials

1 actively recruiting trial

Also known as: Dabrafenib, Trametinib

Top Sponsors

  • Fujian Medical University1

Indications

  • Thyroid Neoplasms1
  • Thyroid Cancer1
  • Cancer1

Other1 trial

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.